UBS Maintains Neutral on Xponential Fitness, Lowers Price Target to $4.5
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
UBS analyst Arpine Kocharyan maintains Xponential Fitness (NYSE:XPOF) with a Neutral and lowers the price target from $7 to $4.5.
UBS analyst Arpine Kocharyan maintains Xponential Fitness (NYSE:XPOF) with a Neutral and lowers the price target from $7 to $4.5.